NCT02821780View on ClinicalTrials.gov

CADASIL Disease Discovery

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 18, 2016

Primary Completion Date

May 3, 2022

Study Completion Date

May 3, 2022

Conditions
Germline Mutation in the NOTCH 3 GeneCardiovascular DiseaseArterial StiffnessPathogenesis of CADASILClinical Phenotype of CADASIL
Trial Locations (2)

20892

National Institutes of Health Clinical Center, Bethesda

43205

Nationwide Children s Hospital, Columbus

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02821780 - CADASIL Disease Discovery | Biotech Hunter | Biotech Hunter